Wednesday, April 6, 2016

BRIEF-Moody's confirms Allergan's Baa3 rating outlook stable

* Baa3 rating reflects allergan's significant scale and good diversity by therapeutic area and product Source text for Eikon: (Bengaluru Newsroom: +1-646-223-8780)


Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)